It's an open label trial, so patients should be well-informed of all developments. Likewise, so is CTIX. But, public release of all information is controlled by Dana Farber and the PI. CTIX needs permission to release any information, including advancement of cohorts.
"It ain't what they call you, it's what
you answer to." --WC Fields
